We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+0.05%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$3.55B
AUM Growth
+$59.4M
Cap. Flow
+$77M
Cap. Flow %
2.17%
Top 10 Hldgs %
49.57%
Holding
665
New
156
Increased
155
Reduced
111
Closed
128

Top Buys

Rank Stock Value
1
HCP
HashiCorp, Inc. Class A Common Stock
HCP
+$138M
2
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
+$131M
3
EDR
Endeavor Group Holdings, Inc.
EDR
+$127M
4
MRO
Marathon Oil Corporation
MRO
+$123M
5
CHX
ChampionX
CHX
+$98.3M

Top Sells

Rank Stock Value
1
PXD
Pioneer Natural Resource Co.
PXD
+$638M
2
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
+$51.2M
3
DFS
Discover Financial Services
DFS
+$45.1M
4
SCRM
Screaming Eagle Acquisition Corp. Class A Ordinary Shares
SCRM
+$18.4M
5
NSC icon
Norfolk Southern
NSC
+$17.7M

Sector Composition

Rank Sector Weight
1 Energy 26.53%
2 Technology 21.03%
3 Healthcare 14.68%
4 Industrials 8.19%
5 Materials 6.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SBGI icon
426
PUT
Sinclair Inc
SBGI
$1.07B
$79.3K ﹤0.01%
+109,400
New +$1.4M
UGI icon
427
PUT
UGI
UGI
$7.44B
$73.5K ﹤0.01%
+71,700
New +$1.74M
UBER icon
428
PUT
Uber
UBER
$153B
$71.3K ﹤0.01%
19,000
-151,000
-89% -$10.5M
EXPE icon
429
PUT
Expedia Group
EXPE
$37.3B
$67.6K ﹤0.01%
13,000
– –
SKT icon
430
PUT
Tanger
SKT
$4.51B
$65.3K ﹤0.01%
+24,200
New +$666K
XBI icon
431
CALL
State Street SPDR S&P Biotech ETF
XBI
$10.2B
$64.2K ﹤0.01%
60,000
-240,000
-80% -$21.5M
VERA icon
432
PUT
Vera Therapeutics
VERA
$2.33B
$58.5K ﹤0.01%
30,000
+10,000
+50% +$397K
TGTX icon
433
CALL
TG Therapeutics
TGTX
$7.6B
$57.8K ﹤0.01%
70,000
-50,000
-42% -$798K
DHR icon
434
PUT
Danaher
DHR
$142B
$54.5K ﹤0.01%
+10,000
New +$2.53M
BPMC
435
PUT
DELISTED
Blueprint Medicines
BPMC
$51K ﹤0.01%
+20,000
New +$2M
TPH
436
PUT
DELISTED
Tri Pointe Homes
TPH
$50.6K ﹤0.01%
+24,700
New +$930K
CVIIW
437
DELISTED
Churchill Capital Corp VII Warrants
CVIIW
$47.4K ﹤0.01%
133,530
– –
AXSM icon
438
CALL
Axsome Therapeutics
AXSM
$10.9B
$46.9K ﹤0.01%
+15,000
New +$1.11M
EPR icon
439
PUT
EPR Properties
EPR
$4.72B
$46.3K ﹤0.01%
+25,700
New +$1.06M
ALNY icon
440
CALL
Alnylam Pharmaceuticals
ALNY
$28.6B
$46K ﹤0.01%
+10,000
New +$1.58M
XIFR
441
PUT
XPLR Infrastructure LP
XIFR
$1.08B
$42.7K ﹤0.01%
27,100
– –
GPK icon
442
PUT
Graphic Packaging
GPK
$3.61B
$42.4K ﹤0.01%
+30,800
New +$851K
SRPT icon
443
CALL
Sarepta Therapeutics
SRPT
$1.76B
$40.5K ﹤0.01%
15,000
-20,000
-57% -$2.57M
CLBR.WS
444
DELISTED
Colombier Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
CLBR.WS
$38.7K ﹤0.01%
133,333
– –
LCW.WS
445
DELISTED
Learn CW Investment Corporation Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
LCW.WS
$38.4K ﹤0.01%
231,102
– –
ARDX icon
446
PUT
Ardelyx
ARDX
$1.02B
$37.5K ﹤0.01%
+100,000
New +$703K
BDTX icon
447
CALL
Black Diamond Therapeutics
BDTX
$111M
$37.1K ﹤0.01%
+46,400
New +$249K
RARE icon
448
CALL
Ultragenyx Pharmaceutical
RARE
$2.59B
$37K ﹤0.01%
40,000
+29,300
+274% +$1.25M
MRUS
449
CALL
DELISTED
Merus
MRUS
$36.8K ﹤0.01%
15,000
-5,000
-25% -$242K
PCVX icon
450
PUT
Vaxcyte
PCVX
$8.78B
$36.5K ﹤0.01%
+10,000
New +$681K
16 17
18
19 20

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return

UBS O'Connor's Q2 2024 Portfolio in Review

As of Q2 2024, UBS O'Connor held 665 positions worth $3.55B, up 1.7% from $3.49B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

UBS O'Connor's Q2 2024 filing shows 156 new, 155 increased, 111 reduced and 128 closed positions. Its largest new stake was Endeavor Group Holdings, Inc.: 4,789,930 shares worth $129M. The largest sale was Pioneer Natural Resource Co., an estimated $638M.

By sector, the portfolio is most concentrated in Energy at 27% of assets, down from 34% a quarter earlier, followed by Technology and Healthcare.

  • UBS O'Connor's largest Q2 2024 buy was Endeavor Group Holdings, Inc.: 4,789,930 shares worth $129M.
  • UBS O'Connor added most to HashiCorp, Inc. Class A Common Stock in Q2 2024, an estimated $138M increase.
  • UBS O'Connor's biggest Q2 2024 reduction was Cerevel Therapeutics Holdings, Inc. Common Stock, cutting an estimated $51.2M.
  • UBS O'Connor fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $638M.
  • UBS O'Connor's ten largest holdings make up 50% of its $3.55B portfolio in Q2 2024.
  • UBS O'Connor opened 156 new positions and closed 128 in Q2 2024.
  • UBS O'Connor's portfolio value rose 1.7% quarter-over-quarter to $3.55B.

Based on UBS O'Connor's 13F filing for Q2 2024, filed 14 Aug 2024.